{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:33Z","timestamp":1792782873834,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["World Health Organization"],"award-info":[{"award-number":["World Health Organization"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"crossref","award":["ViiV Healthcare"],"award-info":[{"award-number":["ViiV Healthcare"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MAC AIDS Fund","award":["MAC AIDS Fund"],"award-info":[{"award-number":["MAC AIDS Fund"]}]},{"DOI":"10.13039\/501100008810","name":"NSW Ministry of Health","doi-asserted-by":"publisher","award":["NSW Ministry of Health"],"award-info":[{"award-number":["NSW Ministry of Health"]}],"id":[{"id":"10.13039\/501100008810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"publisher","award":["Department of Health and Aged Care, Australian Government"],"award-info":[{"award-number":["Department of Health and Aged Care, Australian Government"]}],"id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10461-025-04969-4","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:33:52Z","timestamp":1763343232000},"page":"1162-1171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing Demand for Long-Acting Injectable PrEP and Emerging PrEP Options for HIV Prevention in Australia: Results from a Cross-Sectional Survey of Men Who have Sex with Men"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9581-1011","authenticated-orcid":false,"given":"Curtis","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-6407","authenticated-orcid":false,"given":"Heather-Marie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5784-7403","authenticated-orcid":false,"given":"Jason J.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9712-9262","authenticated-orcid":false,"given":"Warittha","family":"Tieosapjaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Grulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0036-3165","authenticated-orcid":false,"given":"Nittaya","family":"Phanuphak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8626-782X","authenticated-orcid":false,"given":"Edwina J.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0446-1354","authenticated-orcid":false,"given":"Bella","family":"Bushby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-084X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-8278","authenticated-orcid":false,"given":"Benjamin R.","family":"Bavinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"7","key":"4969_CR1","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1016\/S2468-2667(21)00112-2","volume":"6","author":"BR Bavinton","year":"2021","unstructured":"Bavinton BR, Grulich AE. HIV pre-exposure prophylaxis: scaling up for impact now and in the future. Lancet Public Health. 2021;6(7):e528-33.","journal-title":"Lancet Public Health"},{"key":"4969_CR2","volume-title":"HIV, viral hepatitis and sexually transmissible infections in australia: annual surveillance report 2023","author":"J King","year":"2023","unstructured":"King J, McManus H, Kwon A, et al. HIV, viral hepatitis and sexually transmissible infections in australia: annual surveillance report 2023. Sydney: Kirby Institute; 2023."},{"key":"4969_CR3","volume-title":"Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in australia: issue 10","author":"C Chan","year":"2024","unstructured":"Chan C, Fraser D, Medland N, et al. Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in australia: issue 10. Sydney: Kirby Institute, UNSW Sydney; 2024."},{"issue":"8","key":"4969_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/1467-9566.13687","volume":"45","author":"AKJ Smith","year":"2023","unstructured":"Smith AKJ, Lancaster K, Rhodes T, Holt M. Dosing practices made mundane: enacting HIV pre-exposure prophylaxis adherence in domestic routines. Sociol Health Illn. 2023;45(8):1747\u201364.","journal-title":"Sociol Health Illn"},{"issue":"12","key":"4969_CR5","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/QAD.0000000000002970","volume":"35","author":"F Jin","year":"2021","unstructured":"Jin F, Amin J, Guy R, et al. Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia. AIDS. 2021;35(12):1987\u201396.","journal-title":"AIDS"},{"issue":"11","key":"4969_CR6","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.1016\/S2352-3018(19)30238-3","volume":"6","author":"LE Coelho","year":"2019","unstructured":"Coelho LE, Torres TS, Veloso VG, et al. Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline. Lancet HIV. 2019;6(11):e788\u201399.","journal-title":"Lancet HIV"},{"key":"4969_CR7","unstructured":"Broady T, Rance J, Brener L et al. Annual report of trends in behaviour 2025: Viral hepatitis, HIV, STIs and sexual health in Australia. 2025, Centre for Social Research in Health, UNSW Sydney."},{"issue":"5","key":"4969_CR8","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s10461-023-04172-3","volume":"28","author":"M Holt","year":"2023","unstructured":"Holt M, Chan C, Broady TR, et al. Variations in HIV prevention coverage in subpopulations of Australian gay and bisexual men, 2017\u20132021: implications for reducing inequities in the combination prevention era. AIDS Behav. 2023;28(5):1469\u201384.","journal-title":"AIDS Behav"},{"issue":"7","key":"4969_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1056\/NEJMoa2101016","volume":"385","author":"RJ Landovitz","year":"2021","unstructured":"Landovitz RJ, Donnell D, Clement ME, et al. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385(7):595\u2013608.","journal-title":"N Engl J Med"},{"key":"4969_CR10","unstructured":"AVAC. PrEPWatch: Country Data. 2025; Available from: https:\/\/www.prepwatch.org\/data-by-country\/"},{"key":"4969_CR11","volume-title":"Innovative oral PrEP service delivery models and the policy, legal, and regulatory barriers to their implementation","author":"T Arapali","year":"2024","unstructured":"Arapali T, Warzywoda S, Smith AKJ, et al. Innovative oral PrEP service delivery models and the policy, legal, and regulatory barriers to their implementation. Sydney: Kirby Institute, UNSW Sydney; 2024."},{"issue":"13","key":"4969_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"LG Bekker","year":"2024","unstructured":"Bekker LG, Das M, Karim A. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N Engl J Med. 2024;391(13):1179\u201392.","journal-title":"N Engl J Med"},{"key":"4969_CR13","unstructured":"Kelley CF, Acevedo-Quinones M, Agwu AL et al. Twice-yearly lenacapavir for HIV prevention in men and gender-diverse persons. N Engl J Med, 2024."},{"issue":"11","key":"4969_CR14","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2352-3018(24)00235-2","volume":"11","author":"MR Kamya","year":"2024","unstructured":"Kamya MR, Balzer LB, Ayieko J, et al. Dynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and kenya: a randomised trial extension. Lancet HIV. 2024;11(11):e736\u201345.","journal-title":"Lancet HIV"},{"issue":"1","key":"4969_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10461-021-03344-3","volume":"26","author":"C Chan","year":"2022","unstructured":"Chan C, Vaccher S, Fraser D, et al. Preferences for current and future PrEP modalities among PrEP-experienced gay and bisexual men in Australia. AIDS Behav. 2022;26(1):88\u201395.","journal-title":"AIDS Behav"},{"key":"4969_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2025-056507","author":"W Tieosapjaroen","year":"2025","unstructured":"Tieosapjaroen W, Chan C, Fraser D, et al. Preferences for pre-exposure prophylaxis service package among men who have sex with men in australia: a discrete choice experiment. Sex Transm Infect. 2025. https:\/\/doi.org\/10.1136\/sextrans-2025-056507.","journal-title":"Sex Transm Infect"},{"key":"4969_CR17","unstructured":"MacGibbon J, Yu S, Broady T, et al. Evolving attitudes to biomedical HIV prevention among gay, bisexual and Queer men and non-binary people: key findings from the prepare project 2023. Centre for Social Research in Health, UNSW Sydney: Sydney, Australia; 2024."},{"issue":"Suppl 2","key":"4969_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26107","volume":"26","author":"L Lorenzetti","year":"2023","unstructured":"Lorenzetti L, Dinh N, van der Straten A, et al. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition. J Int AIDS Soc. 2023;26(Suppl 2):e26107.","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"4969_CR19","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s10461-022-03949-2","volume":"27","author":"E Toska","year":"2023","unstructured":"Toska E, Zhou S, Chen-Charles J, et al. Factors associated with preferences for long-acting injectable antiretroviral therapy among adolescents and young people living with HIV in South Africa. AIDS Behav. 2023;27(7):2163\u201375.","journal-title":"AIDS Behav"},{"issue":"10","key":"4969_CR20","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/QAD.0000000000003620","volume":"37","author":"D Barthold","year":"2023","unstructured":"Barthold D, Saldarriaga EM, Brah AT, et al. Preference for daily oral pills over long-acting antiretroviral therapy options among people with HIV. AIDS. 2023;37(10):1545\u201353.","journal-title":"AIDS"},{"key":"4969_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00341","volume":"5","author":"SJ Vaccher","year":"2017","unstructured":"Vaccher SJ, Gianacas C, Templeton DJ, et al. Baseline preferences for daily, event-driven, or periodic HIV pre-exposure prophylaxis among gay and bisexual men in the PRELUDE demonstration project. Front Public Health. 2017;5:341.","journal-title":"Front Public Health"},{"issue":"7","key":"4969_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz287","volume":"6","author":"VJ Cornelisse","year":"2019","unstructured":"Cornelisse VJ, Lal L, Price B, et al. Interest in switching to on-demand HIV pre-exposure prophylaxis (PrEP) among Australian users of daily prep: an online survey. Open Forum Infect Dis. 2019;6(7):ofz287.","journal-title":"Open Forum Infect Dis"},{"key":"4969_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1018983","volume":"11","author":"M Ung","year":"2023","unstructured":"Ung M, Martin S, Terris-Prestholt F, et al. Preferences for HIV prevention strategies among newly arrived Asian-born men who have sex with men living in Australia: a discrete choice experiment. Front Public Health. 2023;11:1018983.","journal-title":"Front Public Health"},{"key":"4969_CR24","volume-title":"PrEP product awareness, preferences, and past experiences among transgender women and men who have sex with men in Asia and Australia: the PrEP APPEAL study report","author":"C Chan","year":"2023","unstructured":"Chan C, Fraser D, Schmidt H-M, et al. PrEP product awareness, preferences, and past experiences among transgender women and men who have sex with men in Asia and Australia: the PrEP APPEAL study report. Sydney: Kirby Institute, UNSW Sydney; 2023."},{"issue":"7","key":"4969_CR25","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1007\/s10461-022-03575-y","volume":"26","author":"A Ogunbajo","year":"2022","unstructured":"Ogunbajo A, Tsai AC, Kanki PJ, Mayer KH. Acceptability of and preferences for long-acting injectable HIV PrEP and other PrEP modalities among sexual minority men in Nigeria, Africa. AIDS Behav. 2022;26(7):2363\u201375.","journal-title":"AIDS Behav"},{"issue":"3","key":"4969_CR26","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1097\/QAI.0000000000002557","volume":"86","author":"ME Levy","year":"2021","unstructured":"Levy ME, Agopian A, Magnus M, et al. Is Long-Acting injectable cabotegravir likely to expand PrEP coverage among MSM in the district of columbia? J Acquir Immune Defic Syndr. 2021;86(3):e80\u20132.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"4969_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/09540121.2020.1778628","volume":"33","author":"A Edeza","year":"2021","unstructured":"Edeza A, Karina Santamaria E, Valente PK, et al. Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies. AIDS Care. 2021;33(6):697\u2013705.","journal-title":"AIDS Care"},{"issue":"1","key":"4969_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom D, Ekstrom AM, Stromdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"4969_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/09564624221106527","volume":"33","author":"J Traikiatphum","year":"2022","unstructured":"Traikiatphum J, Wongharn P, Moonwong J, et al. Retention in event-driven PrEP among young Thai men who have sex with men at risk of HIV acquisition. Int J STD AIDS. 2022;33(8):799\u2013805.","journal-title":"Int J STD AIDS"},{"issue":"5","key":"4969_CR30","doi-asserted-by":"publisher","first-page":"e25733","DOI":"10.1002\/jia2.25733","volume":"24","author":"HJ Wu","year":"2021","unstructured":"Wu HJ, Wen-Wei Ku S, Chang HH, et al. Imperfect adherence in real life: a prevention-effective perspective on adherence to daily and event-driven HIV pre-exposure prophylaxis among men who have sex with men - a prospective cohort study in Taiwan. J Int AIDS Soc. 2021;24(5):e25733.","journal-title":"J Int AIDS Soc"},{"key":"4969_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16142620","author":"L Peng","year":"2019","unstructured":"Peng L, Cao W, Gu J, et al. Willingness to use and adhere to HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China. Int J Environ Res Public Health. 2019. https:\/\/doi.org\/10.3390\/ijerph16142620.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"4969_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048478","volume":"12","author":"O Murchu","year":"2022","unstructured":"Murchu O, Marshall E, Teljeur L. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478.","journal-title":"BMJ Open"},{"key":"4969_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101347","volume":"46","author":"K Kripke","year":"2022","unstructured":"Kripke K, Eakle R, Cheng A, et al. The case for prevention - Primary HIV prevention in the era of universal test and treat: a mathematical modeling study. EClinicalMedicine. 2022;46:101347.","journal-title":"EClinicalMedicine"},{"key":"4969_CR34","doi-asserted-by":"publisher","first-page":"SH25026","DOI":"10.1071\/SH25026","volume":"22","author":"CK Fairley","year":"2025","unstructured":"Fairley CK, Ong JJ, Zhang L, et al. Do Australian sexual health clinics have the capacity to Meet demand? A mixed methods survey of directors of sexual health clinics in Australia. Sex Health. 2025;22:SH25026.","journal-title":"Sex Health"},{"issue":"1","key":"4969_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1071\/SH20172","volume":"18","author":"R Janamnuaysook","year":"2021","unstructured":"Janamnuaysook R, Green KE, Seekaew P, et al. Demedicalisation of HIV interventions to end HIV in the Asia-Pacific. Sex Health. 2021;18(1):13\u201320.","journal-title":"Sex Health"},{"key":"4969_CR36","unstructured":"World Health Organization. Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance. 2022."},{"key":"4969_CR37","unstructured":"World Health Organization. WHO implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection: provider module for oral and long-acting PrEP. 2024."},{"issue":"1","key":"4969_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/COH.0000000000000899","volume":"20","author":"RR Patel","year":"2025","unstructured":"Patel RR, Mayer KH. Why is roll-out of long-acting PrEP agents so slow? Curr Opin HIV AIDS. 2025;20(1):48\u201353.","journal-title":"Curr Opin HIV AIDS"},{"issue":"1","key":"4969_CR39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/asj\/sjad211","volume":"44","author":"SH Han","year":"2023","unstructured":"Han SH, Safeek R, Ockerman K, et al. Public interest in the off-label use of Glucagon-like peptide 1 agonists (Ozempic) for cosmetic weight loss: a Google trends analysis. Aesthet Surg J. 2023;44(1):60\u20137.","journal-title":"Aesthet Surg J"},{"key":"4969_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11904-024-00704-1","volume":"21","author":"C McGuire","year":"2024","unstructured":"McGuire C, Atieno MA, Hoke T, et al. PrEP method switching: will it yield greater coverage of HIV protection? Applying lessons learned from family planning to guide future research in the context of PrEP choice. Curr HIV\/AIDS Rep. 2024;21:282\u201392.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"4969_CR41","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0306-4603(02)00300-3","volume":"27","author":"EM Rogers","year":"2002","unstructured":"Rogers EM. Diffusion of preventive innovations. Addict Behav. 2002;27(6):989\u201393.","journal-title":"Addict Behav"},{"key":"4969_CR42","volume-title":"Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia: issue #12, March 2025","author":"C Chan","year":"2025","unstructured":"Chan C, Medland N, McManus H, et al. Monitoring HIV pre-exposure prophylaxis (PrEP) uptake in Australia: issue #12, March 2025. Sydney: Kirby Institute, UNSW Sydney; 2025."},{"issue":"2","key":"4969_CR43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1071\/AH22209","volume":"47","author":"C Rudge","year":"2023","unstructured":"Rudge C, Ghinea N. Promoting the personal importation of therapeutic goods: recent legislative amendments to advertising regulations may impact consumer access and understanding. Aust Health Rev. 2023;47(2):182\u201391.","journal-title":"Aust Health Rev"},{"issue":"2","key":"4969_CR44","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1016\/S2214-109X(23)00536-3","volume":"12","author":"R Zhao","year":"2024","unstructured":"Zhao R, Fairley CK, Cook AR, et al. Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and china: a modelling study and cost-effectiveness analysis. Lancet Glob Health. 2024;12(2):e243\u201356.","journal-title":"Lancet Glob Health"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04969-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04969-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04969-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:11:11Z","timestamp":1776067871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04969-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4969"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04969-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"3 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Benjamin R. Bavinton and Jason J. Ong have received unrestricted research grants, travel and honoraria from Gilead Sciences and ViiV Healthcare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study was approved by the University of New South Wales (UNSW) Human Research Ethics Committee (HC210729). The WHO Ethics Review Committee exempted the study from review, negating the need for separate ethics approvals in participating countries.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants gave informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}